Lacipil 4 mg filmom obložene tablete
| Name | Lacipil 4 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-256476147 |
| Active Substance | lacidipin |
| Composition | 1 filmom obložena tableta sadrži 4 mg lacidipina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Glaxo Wellcome S.A., Aranda de Duero, Burgos, Španjolska Delpharm Poznan S.A., Poznanj, Poljska |
| Marketing Authorisation Holder | GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 20.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/55 |
| Registration Number | 381-12-01/70-21-15 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C08CA09 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
